MagnaSci Ventures

SCI Investments is a London-based venture capital firm backing early-stage companies developing therapies and technologies for spinal cord injury, paralysis and related neurological conditions. Its thesis focuses on clinical impact, scientific maturity and venture-scale returns through an evergreen model that recycles proceeds. The firm’s investment profile also includes India exposure and a later-stage venture transaction in mobility, transportation and sharing-economy models, making it most relevant to founders in life sciences, healthtech, medical devices and adjacent technology sectors.